







Wellbutrin (bupropion) is an antidepressant and is used to support smoking cessation. Here’s how three people describe what the effects of Wellbutrin feel like.
‘I don’t know who I am without it’: the truth about long-term antidepressant use
Prescriptions have doubled in a decade, but very little is known about the effect of taking SSRIs for years. Is it a lifesaver or a happiness trap?

Enhancement of nootropic effect of duloxetine and bupropion by caffeine in mice
Objective: The existing evidence suggests an association between depression and memory impairment. The objective of present study was to assess the effect of low dose caffeine with duloxetine and bupropion on memory. Materials and Methods: Mice were divided randomly into seven groups. Intra-peritoneal treatment of normal saline (10 ml/kg), caffeine (10 mg/kg), duloxetine (10 mg/kg), bupropion alone (10 mg/kg), caffeine + duloxetine (5 mg/kg, each), caffeine + bupropion (5 mg/kg, each), and bupropion + duloxetine (5 mg/kg, each) were given to groups I-VII, respectively. Elevated plus maze was used to evaluate transfer latency (TL) and Morris water maze was used to estimate the time spent in target quadrant. Results: Caffeine with duloxetine treated group was better than other combination treated groups in terms of a significant decrease in TL and increase in the time spent in target quadrant recorded. Conclusion: Combining lower dose of caffeine with duloxetine may enhance cognitive benefits than respective monotherapies.

Magic Mushroom Drug Lifts Depression in Human Trial
Psilocybin shows higher remission rate than SSRI drugs in a U.K. study

Study: Smoking pot doesn’t make you anxious or depressed
And it's definitely not as bad for your brain as the DEA says.

A Dose of a Hallucinogen From a ‘Magic Mushroom,’ and Then Lasting Peace (Published 2016)
Two studies used psilocybin to see if the drug could reduce depression and anxiety in cancer patients. The results were striking.

Single dose of psychedelic drug eased cancer patients' anxiety, depression for years
The new research looked at cancer patients who took part in a study nearly five years ago.

New mechanism proposed for why some psychedelics act as antidepressants
We know what receptors they bind, but where they bind them might matter, too.

Appnome analysis reveals small or no associations between social media app-specific usage and adolescent well-being
The debate on how social media use (SMU) influences adolescent well-being is mostly based on self-reports of SMU. By collecting data and screenshots donated from 374 Swiss adolescents (Meanage = 15.71; SDage = 0.82) over 2 weeks, we created “Appnomes”—app-specific usage metrics on screentime, number of activations, and number of notifications per participant per day derived, and associated them with daily hedonic and eudaimonic well-being. Longer TikTok time predicted lower eudaimonic well-being (β = − 0.08) daily but higher positive emotions (β = 0.06) the next day; longer use of WhatsApp predicted negative emotions (β = 0.06) while more screen activations for WhatsApp predicted greater feelings of connection (β = 0.08). Instagram notification was positively related to increased feeling of focused (β = 0.06) the next day. YouTube screen unlocks predicted more feeling of meaning (β = 0.07) the next day. More Snapchat screentime predicted less relaxed, less competent, and less positive emotions (with − 0.07 < β < − 0.06). Results pointed towards minimal or no effects, challenging the moral panic on the detrimental impact of SMU on teen well-being.

Little evidence that chemical imbalance causes depression, UCL scientists find
Researchers question use of antidepressants, prescribed to one in six UK adults

Psilocybin Treatment for Major Depression Effective for Up to a Year for Most Patients, Study Shows
Previous studies by Johns Hopkins Medicine researchers showed that psychedelic treatment with psilocybin relieved major depressive disorder symptoms in adults for up to a month. Now, in a follow-up study of those participants, the researchers report that the substantial antidepressant effects of psilocybin-assisted therapy, given with supportive psychotherapy, may last at least a year for some patients.

What Bipolar Disorder II Feels Like | Psych Central
Bipolar II is often described as less intense than bipolar I but that's actually not true. Learn one woman's story and what makes bipolar II just as serious.

Serotonin Transporters Increase When Depression Fades - Neuroscience News
Neuroimaging revealed serotonin transporter levels increased in people who were in recovery from depression following cognitive behavioral therapy.

Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities
Classical psychedelics are psychoactive substances, which, besides their psychopharmacological activity, have also been shown to exert significant modulatory effects on immune responses by altering signaling pathways involved in inflammation, cellular proliferation and cell survival via activating NF-κB and MAPKs. Recently, several neurotransmitter receptors involved in the pharmacology of psychedelics, such as serotonin and sigma-1 receptors, have also been shown to play crucial roles in numerous immunological processes. This emerging field also offers promising treatment modalities in the therapy of various diseases including autoimmune and chronic inflammatory conditions, infections, and cancer. However, the scarcity of available review literature renders the topic unclear and obscure, mostly posing psychedelics as illicit drugs of abuse and not as physiologically relevant molecules or as possible agents of future pharmacotherapies. In this paper, the immunomodulatory potential of classical serotonergic psychedelics, including N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-iodoamphetamine (DOI) and 3,4-methylenedioxy-methamphetamine (MDMA) will be discussed from a perspective of molecular immunology and pharmacology. Special attention will be given to the functional interaction of serotonin and sigma-1 receptors and their cross-talk with Toll-like and RIG-I-like pattern recognition receptor-mediated signaling. Furthermore, novel approaches will be suggested feasible for the treatment of diseases with chronic inflammatory etiology and pathology, such as atherosclerosis, rheumatoid arthritis, multiple sclerosis, schizophrenia, depression and Alzheimer's disease.

How Magic Mushrooms Can Help Smokers Kick The Habit : Short Wave
Magic mushrooms — they're not just for getting weird with your friends. Researchers are increasingly looking at psychedelics to treat conditions such as depression and addiction.

Is everything you think you know about depression wrong?
In this extract from his new book, Johann Hari, who took antidepressants for 14 years, calls for a new approach

Serotonin Helps Your Brain Predict Future Rewards - Neuroscience News
New research reveals that serotonin plays a key role in how the brain predicts future rewards, shedding light on its puzzling activity in response to both pleasure and pain.
